Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Pratik P Rane"'
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
BACKGROUND:It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is
Externí odkaz:
https://doaj.org/article/aa44eb78faa142d28b2d153fb8b07228
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading cause
Externí odkaz:
https://doaj.org/article/47de6d83d8e44bb1a35183f9cff78113
Autor:
Fei-Yuan Hsiao, Wen-Jone Chen, Lian-Yu Lin, Yi Qian, Pratik P. Rane, Kathleen M. Fox, Yao-Chun Wen, Li-Jiuan Shen, Zhongyun Zhao
Publikováno v:
Journal of Evaluation in Clinical Practice. 26:1171-1180
Objectives To assess treatment patterns of statin and/or ezetimibe and possible statin intolerance among patients initiating statin or statin plus ezetimibe and with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a6e9333a4dcc911a23c92c74467b49
https://doi.org/10.1111/jep.13286
https://doi.org/10.1111/jep.13286
Autor:
Gordon G. Liu, Nathan Williams, Jason Shepherd, H. Bailey, Zhongyun Zhao, Yi Qian, Pratik P. Rane
Publikováno v:
Journal of Drug Assessment
Objective: To describe characteristics of patients with dyslipidemia treated in routine care in China overall and stratified by diabetes and atherosclerotic cardiovascular disease (ASCVD). Methods: This study used data from a cross-sectional survey c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe1260bfd8ab02e213f642d31ea8e8de
http://europepmc.org/articles/PMC6844391
http://europepmc.org/articles/PMC6844391
Autor:
Yi Qian, Michal Vrablík, Alberico L. Catapano, Olov Wiklund, Mona L. Martin, Pratik P. Rane, Alyson Grove
Publikováno v:
Advances in Therapy
Introduction Statin intolerance (SI) occurs in patients with dyslipidemia treated with statins. Statin-associated symptoms have been reported, but the overall patient experience is poorly understood. No instruments are available to collect this patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f070ebcbdaff44b01bc547c0e69c6bb
http://europepmc.org/articles/PMC6822972
http://europepmc.org/articles/PMC6822972
Autor:
Nigel Armstrong, Lisa Stirk, Yi Qian, Pratik P. Rane, Steve Ryder, Kathleen M. Fox, Sohan Deshpande, Ching-Yun Wei, Jos Kleijnen
Publikováno v:
PharmacoEconomics. 37:895-919
IntroductionThere is a lack of comprehensive cost information for cardiovascular events since 2013.ObjectiveA systematic review on the contemporary cost of cardiovascular events was therefore undertaken.MethodsMethods complied with those recommended
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982774f406f507f3a9401738617d1c53
https://doi.org/10.1007/s40273-019-00795-4
https://doi.org/10.1007/s40273-019-00795-4
Publikováno v:
Research in Social and Administrative Pharmacy. 13:358-363
Background Proton pump inhibitors (PPIs) can lead to several adverse effects among the elderly, particularly when used inappropriately or in contrast to evidence suggested protocols. Objective The aim of this study was to examine the prevalence and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56aa9f8b6bf1cdd69ad93f78a0406a75
https://doi.org/10.1016/j.sapharm.2016.02.012
https://doi.org/10.1016/j.sapharm.2016.02.012
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
Background It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d66c7812ad751c100fdf71e7e81a83c0
https://pubmed.ncbi.nlm.nih.gov/31999714
https://pubmed.ncbi.nlm.nih.gov/31999714
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Public Health
BMC Public Health
Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading causes of mort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07e0b11197aec8e65d54c8b47fb2224
https://doi.org/10.1186/s12889-019-7439-0
https://doi.org/10.1186/s12889-019-7439-0
Autor:
Saurabh P Nagar, Kathleen M. Fox, Pratik P. Rane, Yi Qian, Juliana Meyers, Hyoe Inomata, Anne Beaubrun, Kouji Kajinami, Keith L. Davis
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 82(4)
Background This study examined treatment patterns, possible statin intolerance, and incidence of cardiovascular events (CVEs) in 2 cohorts of patients with high cardiovascular risk (i.e., patients with atherosclerotic cardiovascular disease [ASCVD] a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727b8c6ff7b0206d9869eb0723ae6ed7
https://pubmed.ncbi.nlm.nih.gov/29526987
https://pubmed.ncbi.nlm.nih.gov/29526987